Adherence to antiretroviral medication among HIV-positive patients in Thailand

Journal of Acquired Immune Deficiency Syndromes

Volumn 43, Issue SUPPL. 1, 2006, Pages

  Maneesriwongul, Wantana Limkulpong ^a   Tulathong, Somchit ^b   Fennie, Kristopher P ^c   Williams, Ann B ^c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Sena Hospital   (Thailand)

^c YALE UNIVERSITY   (United States)

Author keywords

Adherence; Thailand; VAS

Indexed keywords

LAMIVUDINE; NEVIRAPINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; VIRUS RNA; ZIDOVUDINE;

ADULT; ARTICLE; COHORT ANALYSIS; EDUCATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; SELF REPORT; SEX DIFFERENCE; STRUCTURED QUESTIONNAIRE; THAILAND; TREATMENT DURATION; VIRUS LOAD; VISUAL ANALOG SCALE;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PATIENT COMPLIANCE; THAILAND; VIRAL LOAD;

EID: 33845364456     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000248346.79888.78     Document Type: Article

References (24)

1. Ho DH, Neumann AU, Perelson AS, et al. Rapid turnover of plasma virion and CD4 lymphocytes in HIV-1 infection. Nature. 1995;373:123-126.
2. Wei X. Viral dynamics in human immunodeficiency virus type I infection. Nature. 1995;373:117-122.
3. Saag MS. Use of HIV viral load in clinical practice: back to the future. Ann Intern Med. 1997;126:983-985.
4. Deeks SK, Smith M, Holodniy M, et al. HIV-1 protease inhibitors. JAMA. 1997;277:145-153.
5. Kraisintu K, Eksaengsri A. Generic production of HIV/AIDS-related drugs in Thailand [abstract MoOrG1038]. Presented at: XIV International AIDS Conference; 2002; Barcelona.
6. Bunjumnong O. Thailand: access to antiretroviral treatment under Universal Health Care Scheme [abstract TuPeG5658]. Presented at: XIV International AIDS Conference; 2002; Barcelona.
7. Bureau of AIDS, TB and STI. Comprehensive and Continuum Care Guideline for Persons Living with HIV/AIDS. Bangkok, Thailand: Disease Control Department, Ministry of Public Health; 2004.
8. Vella S. Clinical implications of resistance to antiviral drugs. AIDS Clin Care. 1997;9:45-52.
9. Bangsberg DR, Hecht FM, Charlebosis ED, et al. Adherence to protease inhibitors, HIV-1 viral load, development of drug resistance in indigent population. AIDS. 2000;14:357-366.
10. Arnsten JH, Demas PA, Fazadegan H, et al. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis. 2001;33:1417-1423.
11. Deleted in Proof.
12. Sittidach M, Chayakul P, Silpapojakul K, et al. Impact of pharmacist counseling on adherence to antiretroviral therapy. Presented at: XV International AIDS Conference; 2004; Bangkok.
13. Tulathong S, Maneesriwongul W, Sirapongam Y. Affective factors to medication adherence among patients receiving highly active antiretroviral therapy. Presented at: Third International Conference on Community Health Nursing Research; 2005; Tokyo.
14. Hanvong S. Knowledge, health belief, and adherence to antiretroviral therapy among people living with HIV/AIDS [thesis]. Thailand: Burapa University, Chonburi; 2005.
15. Safren SA, Kumarasamy N, James R, et al. ART adherence, demographic variables and CD4 outcomes among HIV-positive patients on antiretroviral therapy in Chennai, India. AIDS Care. 2005;17:853-862.
16. Li H, Wang Z, Cui WG, et al. Study on adherence and interrelated factors of acquired immunodeficiency syndrome patients receiving antiretroviral treatment [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi. 2005;26:507-510.
17. Jenwitheesuk E, Watitpun C, Vibhagool A, et al. Prevalence of genotypic HIV-1 drug resistance in Thailand, 2002. Ann Clin Microbiol Antimicrob. 2003;2:4.
18. Sutthent R, Arworn D, Kaoriangudom S, et al. HIV-1 drug resistance in Thailand: before and after national access to antiretroviral program. J Clin Virol. 2005;34:272-276.
19. Ministry of Public Health. National Guidelines for the Clinical Management of HIV Infection in Children and Adults. 6th ed. Bangkok, Thailand: Ministry of Public Health; 2000.
20. Ministry of Public Health. Practice Guidelines on Development of Health Service and Monitoring System for Persons Living with HIV/AIDS Receiving Antiretroviral Therapy. Bangkok, Thailand:Ministry of Public Health; 2003.
21. Walsh JC, Mandalia S, Gazzard BG. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS. 2002;16:269-277.
22. Giordano T, Guzman D, Clark R, et al. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials. 2004;5:74-79.
23. Oyugi JH, Byakika-Tusiime JB, Charlebois ED, et al. Multiple validated measures of adherence indicate high level of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J Acquir Immune Defic Syndr. 2004;36:1100-1102.
24. Parienti JJ, Massari V, Descamps D, et al. Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy. Clin Infect Dis. 2004;38:1311-1316.